Mozenavir
- Level
- Commodity
- Parent
- 51343300
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343304This classification denotes a protease inhibitor with the molecular formula C33H36N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64OO8946ER. The term MOZENAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule mozenavir under HS 29339940 and SITC 51577. As of Q4 2014, MOZENAVIR remains the US FDA Preferred Term for this commodity. Mozenavir bears US NLM identifiers UMLS ID C0390428 and NCI Concept Code C77390. SMILES: C1=CC=C(C=C1)CC2C(C(C(N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O.
Same parent
Under 51343300 · 10Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.